Announcements

A Form 4 filed on August 12, 2026 discloses that Nirav R Shah, a director of STERIS plc (NYSE:STE), acquired Director Stock Options and Career Restricted Stock Units on August 10, 2026.

A Form 4 filed on August 12, 2026 discloses that Mohsen Sohi, a director of STERIS plc (NYSE:STE), exercised a stock option for 4,058 ordinary shares and sold those shares on the same date, while also receiving new stock options and Career Restricted Stock …

A Form 4 filed with the SEC on August 12, 2026, discloses that Barbara A. Larson, a director of Equifax Inc. (NYSE:EFX), acquired phantom stock units on August 10, 2026, as deferred compensation under the company's Board of Directors Deferred Compensation Plan.

Director Vikas Choudhary filed a Form 4 with the SEC on August 12, 2026, disclosing the acquisition of restricted stock units in Everspin Technologies Inc. (NASDAQ:MRAM) on August 10, 2026.

Mark Sullivan, Chief Legal Officer of Definium Therapeutics, Inc. (NASDAQ:DFTX), filed a Form 4 on August 12, 2026, disclosing the acquisition of 62,500 common shares at $0.00 through the vesting of performance share units.

A Form 4 filed on August 12, 2026 discloses that Charles S. Fuchs, President of R&D at Erasca, Inc. (NASDAQ:ERAS), was granted stock options covering 1,300,000 shares of common stock on August 10, 2026, in connection with his commencement of employment.

Director Patricia Mulroy filed a Form 4 with the SEC on August 12, 2026, reporting the sale of 883 shares of Bowman Consulting Group Ltd. common stock on August 10, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.